EPO and Huntington disease: Stratified Cox proportional hazard regressions showed that the hazard ratio (HR) for dementia in HD patients who took EPO within the follow-up period was 0.48 [95% confidence interval (CI) 0.42 to 0.54; p<0.0001] in comparison with the HD patients in the non-EPO cohort.